Peterson & Associates, P.C.

Our Blog

Actos Bladder Cancer Side Effects

Published
Categorized as Actos

Actos® (generic pioglitazone hydrochloride) is prescription drug used for treatment of Type 2 diabetes. Recent studies have revealed that Actos patients may face an increased risk of bladder cancer from the extended use of Actos.

If you or a loved one has taken Actos® and have symptoms of or have been diagnosed with Bladder Cancer, Contact Peterson & Associates, P.C. for a FREE Actos Bladder Cancer Legal Review.

About Actos

Actos, a diabetes prescription drug. Pioglitazone, the generic name for Actos has been sold under the trade names Actos, Actoplus MET, Competact and Duetact.

Actos has been shown by recent studies to potentially cause an increased risk of bladder cancer.

Contact Peterson & Associates, P.C. for a FREE Actos® Bladder Cancer Legal Consultation.

Actos Side Effects

Actos (generic pioglitazone hydrochloride) is a prescription drug used for treatment of Type 2 diabetes. Recent studies have revealed that Actos patients may face an increased risk of bladder cancer from the extended use of Actos.

Actos Side Effects & Symptoms of Bladder Cancer:

  • Blood in Urine
  • Pain during Urination
  • Feeling of Need to Urinate

If you or a loved one has taken Actos® and have symptoms of or have been diagnosed with Bladder Cancer, Contact Peterson & Associates, P.C. for a FREE Actos Bladder Cancer Legal Review.

Actos® Bladder Cancer Lawsuit Information

Recently a 10 year study revealed that diabetes patients who took Actos® for an extended period of time may be at risk for developing Bladder Cancer.

In September 2010, the FDA announced that makers of Actos®, Takeda Pharmaceuticals, provided data after five years of the study that suggests there may be a risk of bladder cancer from Actos®. According to the study, if a patient has taken Actos® for more than 24 months, they may be at an increased risk of Bladder Cancer from Actos® side effects.

It appears that this information about the potential risk of Actos® cancer problems has been known to Takeda, manufacturer of Actos®, for a period of time, warnings were provided to consumers and the medical community. Some experts believe that recall should be issued or that new warnings about the risk of bladder cancer from Actos® should be added to the medication.

If you or a loved one has taken Actos® and have symptoms of or have been diagnosed with bladder cancer, Contact Peterson & Associates, P.C. for a FREE Actos Bladder Cancer Legal Review.

It appears that this information about the potential risk of Actos® cancer problems has been known to Takeda, manufacturer of Actos®, for a period of time, warnings were provided to consumers and the medical community. Some experts believe that recall should be issued or that new warnings about the risk of bladder cancer from Actos® should be added to the medication.

Actos® was recently withdrawn from the market in France and Germany due to its association with bladder tumors. Due to these and other serious side effects, the FDA recently announced a link between Actos® and an increased incidence of bladder cancer.

If you or a loved one has taken Actos® and have symptoms of or have been diagnosed with Bladder Cancer, Contact Peterson & Associates, P.C. for a FREE Actos Bladder Cancer Legal Review.